home / stock / fbio / fbio articles


FBIO Articles, Fortress Biotech Inc. - From 10/26/23

Stock Information

Company Name: Fortress Biotech Inc.
Stock Symbol: FBIO
Market: NASDAQ
Website: fortressbiotech.com

Menu

FBIO FBIO Quote FBIO Short FBIO News FBIO Articles FBIO Message Board
Get FBIO Alerts

News, Short Squeeze, Breakout and More Instantly...

Mustang Bio Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules | Benzinga

WORCESTER, Mass., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. ("Mustang" or the "Company") (NASDAQ:MBIO), a clinical-stage biopharmaceut...

Fortress Biotech to Present at ROTH MKM 2023 Healthcare Opportunities Conference | Benzinga

MIAMI, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ:FBIO) ("Fortress"), an innovative biopharmaceutical company focused on e...

Checkpoint Therapeutics Announces Exercise of Warrants for $11.13 Million in Gross Proceeds | Benzinga

WALTHAM, Mass., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a clinical-stage immunotherapy and...

GeoVax Labs And 3 Other Stocks Under $1 Insiders Are Buying | Benzinga

The Dow Jones closed lower by around 69 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around...

Checkpoint Therapeutics to Participate in the Cantor Global Healthcare Conference | Benzinga

WALTHAM, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a clinical-stage immunotherapy an...

Fortress Biotech to Present at H.C. Wainwright 25th Annual Global Investment Conference | Benzinga

MIAMI, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ:FBIO) ("Fortress"), an innovative biopharmaceutical company focused on ...

Mustang Bio to Participate in Upcoming September 2023 Investor Conferences | Benzinga

WORCESTER, Mass., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. ("Mustang") (NASDAQ:MBIO), a clinical-stage biopharmaceutical company foc...

Checkpoint Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference | Benzinga

WALTHAM, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a clinical-stage immunotherapy an...

Previous 10 Next 10